James E. Audia

James E. Audia

Director/Board Member at Ribon Therapeutics, Inc.

68 year
Health Technology
Consumer Services
Commercial Services

Profile

James E.
Audia
is currently the Director at Ribon Therapeutics, Inc. and a Member at Alzheimer's Association.
Previously, he served as the Independent Director at Constellation Pharmaceuticals, Inc. from 2011 to 2021.
He was also the Executive Director at Chicago Biomedical Consortium from 2017 to 2019.
Additionally, he held the position of Head-Chemistry at Karuna Therapeutics, Inc. from 2019 to 2024.
Dr. Audia obtained his doctorate degree from Yale University and the University of South Carolina.

James E. Audia active positions

CompaniesPositionStart
Director/Board Member 2018-03-31
Corporate Officer/Principal 2019-12-31
All active positions of James E. Audia

Former positions of James E. Audia

CompaniesPositionEnd
KARA THER Corporate Officer/Principal 2024-03-17
CONSTELLATION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2017-06-30
Chicago Biomedical Consortium Director/Board Member 2019-09-30
See the detail of James E. Audia's experience

Training of James E. Audia

Yale University Doctorate Degree
University of South Carolina Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James E. Audia's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies5

Commercial Services

Health Technology

Health Technology

Health Technology

Chicago Biomedical Consortium

See company connections
  1. Stock Market
  2. Insiders
  3. James E. Audia